Hikma takes on Perrigo lines
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Perrigo has struck a licensing and distribution agreement with Hikma, granting the Jordanian generics specialist the rights to market a range of its consumer healthcare products in the Middle East and North Africa (MENA) region.
You may also be interested in...
People On The Move: Appointments At Haleon, Hikma And ANEFP
A round-up of the latest European consumer health industry appointments: GSK adds three to Haleon's board; Hikma's chairman Darwazah becomes interim CEO as Olafsson departs; and ANEFP re-elects Bueno as president.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.
Report Finds Digital Diabetes Tools Deliver No ‘Meaningful Clinical Benefits'
A new report from health economics group the Peterson Health Technology Institute found that apps to help patients manage their blood sugar levels delivered few of the promised benefits. However, a digital therapeutics industry association says PHTI’s research cast too narrow a net.